Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07066709 · ClinicalTrials.gov registry record · Phase 2

Painful Post-Operative Hip Study

A Phase 2 study of Unilateral Hip Arthroscopy, sponsored by University of Wisconsin, Madison.

Recruiting
Registry status
Phase 2
Development phase
15
Enrollment target
1
Study location

NCT07066709 is a Phase 2 study of Unilateral Hip Arthroscopy that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 15 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07066709, a Phase 2 study of Unilateral Hip Arthroscopy, is actively recruiting participants, sponsored by University of Wisconsin, Madison.

RECRUITING
Registry status
Phase 2
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to learn if the hips of people who undergo revision hip arthroscopy look different from the hips of people whose hip pain is resolved with the first hip arthroscopy and of people who choose the steroid injection for pain management. Participants will complete one PET/MRI scan.

Conditions Studied

Interventions

  • COMBINATION_PRODUCT FDG PET/MRI

Study Locations (1)

Wisconsin

  • University of Wisconsin - Madison - Madison

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2026-01-21
Est. Completion 2026-11
Phase Phase 2

Sponsor

University of Wisconsin, Madison

1,039 total trials

What the Registry Record Tells You About NCT07066709

The ClinicalTrials.gov registry entry for NCT07066709 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Unilateral Hip Arthroscopy appearing as the primary indexed condition, and to 1 intervention - of which FDG PET/MRI is the first listed.

NCT07066709 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.

Frequently Asked Questions

What is clinical trial NCT07066709 about?

NCT07066709 is a clinical study titled "Painful Post-Operative Hip Study". The goal of this clinical trial is to learn if the hips of people who undergo revision hip arthroscopy look different from the hips of people whose hip pain is resolved with the first hip arthroscopy and of people who choose the steroid injection for pain management. Participants will complete one ...

What is the current status of trial NCT07066709?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 15 participants. The study started on 2026-01-21. Estimated completion is 2026-11.

What conditions does trial NCT07066709 study?

This clinical trial studies the following conditions: Unilateral Hip Arthroscopy.

What interventions are being tested in trial NCT07066709?

The interventions under investigation include: FDG PET/MRI (COMBINATION_PRODUCT).

Who is sponsoring clinical trial NCT07066709?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07066709 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.